» Articles » PMID: 22586367

Molecular Mechanisms of Cys-loop Ion Channel Receptor Modulation by Ivermectin

Overview
Specialty Molecular Biology
Date 2012 May 16
PMID 22586367
Citations 32
Authors
Affiliations
Soon will be listed here.
Abstract

Ivermectin is an anthelmintic drug that works by inhibiting neuronal activity and muscular contractility in arthropods and nematodes. It works by activating glutamate-gated chloride channels (GluClRs) at nanomolar concentrations. These receptors, found exclusively in invertebrates, belong to the pentameric Cys-loop receptor family of ligand-gated ion channels (LGICs). Higher (micromolar) concentrations of ivermectin also activate or modulate vertebrate Cys-loop receptors, including the excitatory nicotinic and the inhibitory GABA type-A and glycine receptors (GlyRs). An X-ray crystal structure of ivermectin complexed with the C. elegans α GluClR demonstrated that ivermectin binds to the transmembrane domain in a cleft at the interface of adjacent subunits. It also identified three hydrogen bonds thought to attach ivermectin to its site. Site-directed mutagenesis and voltage-clamp electrophysiology have also been employed to probe the binding site for ivermectin in α1 GlyRs. These have raised doubts as to whether the hydrogen bonds are essential for high ivermectin potency. Due to its lipophilic nature, it is likely that ivermectin accumulates in the membrane and binds reversibly (i.e., weakly) to its site. Several lines of evidence suggest that ivermectin opens the channel pore via a structural change distinct from that induced by the neurotransmitter agonist. Conformational changes occurring at locations distant from the pore can be probed using voltage-clamp fluorometry (VCF), a technique which involves quantitating agonist-induced fluorescence changes from environmentally sensitive fluorophores covalently attached to receptor domains of interest. This technique has demonstrated that ivermectin induces a global conformational change that propagates from the transmembrane domain to the neurotransmitter binding site, thus suggesting a mechanism by which ivermectin potentiates neurotransmitter-gated currents. Together, this information provides new insights into the mechanisms of action of this important drug.

Citing Articles

Structural mechanisms of α7 nicotinic receptor allosteric modulation and activation.

Burke S, Avstrikova M, Noviello C, Mukhtasimova N, Changeux J, Thakur G Cell. 2024; 187(5):1160-1176.e21.

PMID: 38382524 PMC: 10950261. DOI: 10.1016/j.cell.2024.01.032.


Patch-clamp studies and cell viability assays suggest a distinct site for viroporin inhibitors on the E protein of SARS-CoV-2.

Breitinger U, Sedky C, Sticht H, Breitinger H Virol J. 2023; 20(1):142.

PMID: 37422646 PMC: 10329798. DOI: 10.1186/s12985-023-02095-y.


Activity of Ivermectin and Its Metabolites against Asexual Blood Stage Plasmodium falciparum and Its Interactions with Antimalarial Drugs.

Yipsirimetee A, Tipthara P, Hanboonkunupakarn B, Tripura R, Lek D, Kumpornsin K Antimicrob Agents Chemother. 2023; 67(7):e0173022.

PMID: 37338381 PMC: 10368210. DOI: 10.1128/aac.01730-22.


Activity disruption causes degeneration of entorhinal neurons in a mouse model of Alzheimer's circuit dysfunction.

Zhao R, Grunke S, Wood C, Perez G, Comstock M, Li M Elife. 2022; 11.

PMID: 36468693 PMC: 9873254. DOI: 10.7554/eLife.83813.


Cannabidiol as a modulator of α7 nicotinic receptors.

Chrestia J, Esandi M, Bouzat C Cell Mol Life Sci. 2022; 79(11):564.

PMID: 36282426 PMC: 11803050. DOI: 10.1007/s00018-022-04600-y.


References
1.
Collins T, Millar N . Nicotinic acetylcholine receptor transmembrane mutations convert ivermectin from a positive to a negative allosteric modulator. Mol Pharmacol. 2010; 78(2):198-204. PMC: 2917854. DOI: 10.1124/mol.110.064295. View

2.
Lee S, MacKinnon R . A membrane-access mechanism of ion channel inhibition by voltage sensor toxins from spider venom. Nature. 2004; 430(6996):232-5. DOI: 10.1038/nature02632. View

3.
Hazai E, Joshi P, Skoviak E, Suryanarayanan A, Schulte M, Bikadi Z . A comprehensive study on the 5-hydroxytryptamine(3A) receptor binding of agonists serotonin and m-chlorophenylbiguanidine. Bioorg Med Chem. 2009; 17(16):5796-805. DOI: 10.1016/j.bmc.2009.07.022. View

4.
Jones A, Sattelle D . The cys-loop ligand-gated ion channel gene superfamily of the nematode, Caenorhabditis elegans. Invert Neurosci. 2008; 8(1):41-7. PMC: 2257991. DOI: 10.1007/s10158-008-0068-4. View

5.
Costa J, Diazgranados J . Ivermectin for spasticity in spinal-cord injury. Lancet. 1994; 343(8899):739. DOI: 10.1016/s0140-6736(94)91625-x. View